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The impact of superficial femoral artery (SFA)
occlusion on the outcome of proximal sartorius
muscle transposition flaps in vascular surgery
patients
Ingolf Töpel, MD, Thomas Betz, MD, Christian Uhl, MD, and Markus G. Steinbauer, MD, Regensburg,
Germany
Objectives: To demonstrate the feasibility and safety of proximal sartorius muscle rotational flaps in patients with
peripheral occlusive artery disease.
Methods: Retrospective analysis of 53 patients with 56 proximal sartorius muscle flaps. Indication for a flap procedure was
postoperative calcitrant lymphorrhea in nine, graft at risk in 13, and graft infection in 34 procedures. Pre- and
postoperative patencies of the superficial femoral artery (SFA) and profundal femoral artery (PFA) were documented.
Flap viability, wound healing, and limb salvage were examined at follow-up.
Results: In 59% of the procedures in this series, the SFA was occluded. The PFA was patent in all patients. Flap viability
(100% vs 94%), rate of new (4% vs 6%), and recurrent infections (9% vs 6%), loss of vascular reconstruction rate (9% vs 9%),
and limb salvage rate (100% vs 88%) did not differ significantly between the SFA patent and the SFA occluded group.
There were four new infections (7%) and three recurrent infections (5.5%) during follow-up, five of which led to a loss of
reconstruction. In four of those five patients, the sartorius flap was viable. Two patients died during the immediate
postoperative period from septic multi-organ failure (3%). At a median follow-up of 6.4 months, 54 flaps were viable and
wound closure was achieved in all surviving 51 patients. Limb salvage rate was 93%.
Conclusions: Biologic protection procedures as local muscle flaps are vital adjuncts to vascular surgery techniques in the
treatment of complicated wounds in the groin. Occlusion of the SFA in the presence of a patent PFA is not associated with
an increased risk of flap loss in proximal sartorius muscle rotational flaps. ( J Vasc Surg 2011;53:1014-9.)
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tDue to anatomic properties and a high microbial load,
the groin is prone to local wound complications after
surgery. Calcitrant lymphorrhea and wound healing distur-
bances may lead to infections jeopardizing vascular recon-
structions in that area. Deep soft tissue infection and skin
breakdown make coverage of vessels and grafts difficult.
After debridement, direct wound closure often is impos-
sible.
The value of local muscle flaps in wound and graft
complications in the groin are well documented.1-3 Ac-
cording to Mathes and Nahai,4 the sartorius muscle is
supplied by segmental branches from the superficial femo-
ral artery (superficial femoral artery [SFA], type IV circula-
tion pattern, segmental supply). Therefore, vascular sur-
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1014eons might hesitate to use the proximal sartorius muscle
ap in patients with an occluded SFA. Ramasastry5 de-
cribed a different supply pattern over branches of the
edial and lateral circumflex artery.
In this study, we analyze the pre- and postoperative
rterial status of SFA and profundal femoral artery (PFA) in
atients with a proximal sartorius muscle rotational flap.
hese data were correlated with clinical end points as flap
urvival, wound healing, recurrence of infection, and graft
reservation.
ATIENTS AND METHODS
Over a period of 38 months (March 2007 to May
010), 56 proximal sartorius muscle flaps were performed
n 53 vascular surgery patients as biologic protection pro-
edure. Indication, epidemiologic, and procedural data are
hown in Tables I and II. At our institution, the standard
reatment plan of patients with surgical site infections af-
ecting a vascular graft (Szilagyi 3, prosthetic, bovine, or
enous) includes a biologic protection procedure. In the
roin, the proximal sartorius muscle flap is our first choice.
n the special situation of impending or manifest infections
f vascular reconstructions, independently from the vascu-
ar procedure, extensive debridement of all necrotic tissue
as done. Mathes and Nahai described the standard surgi-
al technique.4 Muscle fascia lateral to the groin vessels and
he femoral nerve is opened longitudinally. It is necessary
nly in few cases to extend the already existing groin
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Volume 53, Number 4 Töpel et al 1015incision cranially to the anterior superior iliac spine. After
exposure of the ventral side, the muscle is cut off its origin
and the dorsal side is carefully mobilized. The vascular
Table I. Patient population: Demographic data
SFA patent
Patients
Sartorius flaps 23
Unilateral/bilateral
Sex (men/women) 18 (78%)/5 (22
Age (years) mean 63
median 67
range 17-87
Risk factors
Hypertension 17 (73%)
Diabetes mellitus 5 (22%)
Smoking 10 (43%)
Hyperlipoproteinemia 6 (26%)
Cardiac history
Coronary heart disease 8 (34%)
Previous CABG or coronary PTCA 5 (22%)
Associated diseases
COPD 5 (22%)
Renal insufficiency (Crea  1.0 mg/dL) 6 (26%)
Indication for flap procedure
Infected graft 11 (48%)
Graft at risk 8 (35%)
Calcitrant lymphorrhea 4 (17%)
Simultaneous vascular procedure
Autologous 13 (56%)
Bovine/prosthetic 2 (9%)
None 8 (35%)
CABG, Coronary artery bypass graft; COPD, chronic obstructive pulmonar
Table II. Procedures
SFA
patent
SFA
occluded All
Operation sites 23 33 56
Initial vascular procedure
Aorto-inguinal 9 6 15
Prosthetic 9 6 15
Aorto-bifemoral BP 5 4 9
Aorto-femoral BP 1 2 3
Iliaco-femoral BP 3 3
Xenogen (bovine Patch)
Autologous
Infrainguinal 14 27 41
Prosthethic 3 21 24
Femoro-femoral BP 2 2
Femoro-femoral CX-BP 1 1 2
Femoro-popliteal BP (supragenual) 9 9
Femoro-popliteal BP (infragenual) 8 8
Femoro-crural BP 3 3
Xenogen (bovine Patch) 5 2 7
TEA femoral artery 5 2 7
Autologous 6 4 10
Femoro-femoral vein BP 1 1
Femoro-popliteal vein BP (supragenual) 2 2
Femoro-popliteal vein BP (infragenual) 1 1
Embolectomy CFA/PFA artery 5 1 6
BP, Bypass; CFA, common femoral artery; CX, crossover; PFA, profundal
femoral artery; TEA, thrombendarterectomy.pedicles are preserved whenever possible. The muscle is wransposed to the vessel and fixated with absorbable su-
ures. After meticulous bleeding control by the use of
ipolar forceps and rinsing of the wound with normal saline
olution, suction drains were placed over and under the flap
nd the wound was closed in single suture technique (32
perating sites). In cases where primary wound closure was
ot feasible due to defects or edema (24 operating sites) or
n cases that were primarily closed but had to be reopened
or incision edge edema (three cases), a vacuum-assisted
ound closure device ([VAC] KCI International, San An-
onio, Tex) was placed on top of the flap and run with
ontinuous negative pressure of 75 mm Hg. The VAC
evice was changed every 3 to 4 days, until secondary
ound closure could be achieved (12 operating sites) or the
ound could be covered with a split thickness skin mesh
raft (15 operating sites).
In eight patients of the SFA patent group and five
atients of the SFA occluded group, the flap was done in a
rophylactic manner, because the surgeon defined the con-
ition of the vascular graft and the wound as prone to
nfection (graft at risk).
Calcitrant lymphorrhea was defined as lymphatic
ound drainage of more than 50 cc per day for more
han seven days postoperatively. Intraoperative wound
waps and cultures of explanted graft specimen were
eviewed and the findings of microbiological analysis was
ocumented in Table III. Pre- and postoperative angiog-
aphies and duplex-ultrasound findings were analyzed with
espect to the patency of SFA and PFA. Flap viability,
SFA occluded All P
53
33 56
50/3
26 (78%)/7 (22%) 44 (78 %)/12 (22%) 1.000
67 65
67 67
53-86 17-87 1.000
29 (88%) 46 (82%) .826
13 (39%) 18 (32%) .464
23 (70%) 33 (59%) .430
11 (33%) 17 (30%) .886
12 (36%) 20 (36%) .856
7 (21%) 12 (21%) 1.000
4 (12%) 9 (16%) .483
13 (39%) 19 (34%) .644
23 (70%) 34 (61%) .547
5 (15%) 13 (23%) .304
5 (15%) 9 (16%) 1.000
21 (64%) 34 (61%) .965
8 (24%) 10 (18%) .297
4 (12%) 12 (21%) .124
ase; PTCA, percutaneous transluminal coronary angioplasty.%)ound healing, graft preservation, and new and recurrent
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April 20111016 Töpel et alinfections were documented. At follow-up, vascular status,
wound status, and functional result were examined.
Data were collected and analyzed using Microsoft Ex-
cel for Mac (Microsoft Corporation, Santa Rosa, Calif).
Statistical comparisons were made using the 2 test with a P
value less than .05 considered significant. If over 20% of the
expected values in the contingency table were less than five,
Fisher exact test was used because the 2 test can be quite
inaccurate in this situation.
RESULTS
Fifty-six proximal sartorius muscle transposition flaps
(30 on the right and 26 on the left side) were performed in
53 patients. Patient characteristics and detailed surgical
data are given in Tables I and II. All angiographies and
CT-scans of the immediate perioperative period were re-
viewed concerning the status of the SFA and PFA. Four
patients with an occluded SFA had a patent proximal seg-
ment (average length 105 mm). The pathologic changes of
the PFA were also documented: It was classified as “nor-
mal” if the diameter was more than 4 mm at the ostium,
and as “small” if the diameter was less than 4 mm. If there
were significant calcifications with stenosis of more than
50% of the lumen or segmental occlusions of10 mm, the
PFA was classified as “diseased.” Given these classifications,
the PFA was patent in all 56 operating sites. Results are
shown in Table IV. We could not find statistically relevant
differences between the SFA patent and the SFA occluded
group concerning the PFA status. The patients were di-
vided into two groups by preoperative patency of the
superficial femoral artery: SFA patent and SFA occluded.
Duplex ultrasound examinations of the vascular recon-
struction were done in all patients preoperatively and dur-
ing the first five postoperative days. There was no difference
between the pre- and postoperative patency status of SFA
or PFA.
All intraoperative wound swaps and cultures of graft
Table III. Microbiologic spectrum
Species
Graft infections
N  34
Recu
Staphylococcus aureus 8
Incl. MRSA 0
Enterococci 2
Incl. Ampicillin-resistant Enterococci 1
Coagulase-neagtive Staphylococci 8
Streptococci 4
Escherichia coli 2
Incl. ESBL 1
Pseudomonas aeroginosa 1
Acinetobacter baumannii 2
Enterobacter cloacae 1
Klebsiella 4
Incl. ESBL 1
Proteus 1
Candida 3
Negative culture 13
Two or more species cultured 7specimen were reviewed and the microbial spectrum was vocumented in Table III. We lost two flaps in the SFA
ccluded group (6%): one due to ischemia (PFA status:
ormal), probably as a result of extensive lateral mobiliza-
ion and division of the two uppermost segmental pedicles.
he necrotic flap was resected 6 days after the first flap
rocedure and a rectus femoris muscle flap was done. A
econd flap was lost due to persistent wound infection with
ulti-resistant bacteria (extended spectrum -lactamase,
SBL; PFA status: small). The necrotic part of the flap was
esected and a rectus femoris muscle flap was done. Both
ound were treated with VAC dressings and closed with
kin grafts. The vascular reconstruction could be preserved
nly in the first case (Tables V and VI). At a median
ollow-up of 6.4 months, 54 viable flaps could be docu-
ented (96.5% success rate). All flaps in the SFA patent
roup were viable (100%). In the SFA occluded group, 94%
f the sartorius flaps were viable (P  .513). In the two
atients with sartorius flap loss, the rectus femoris flap was
able IV. Femoral artery status
SFA patent
N  23
SFA occluded
N  33 P
FA-status
Patent 23
omplete occlusion 29
roximal patent (median
105 mm) 4
FA-status
ormal (4 mm) 16 17 .966
mall (4 mm) 0 7
iseased
Calcified, segmental
stenosis
4 7 .875
Segmental occlusion 3 2
FA, Profundal femoral artery; SFA, superficial femoral artery.
infections
4
New infections
N  3
Failed flaps
N  2
Loss of reconstruction
N  5
1 0 1
0 0 0
1 1 2
0 0 0
2 2 3
0 0 0
0 1 1
0 1 1
0 0 0
1 0 1
0 0 0
1 2 1
0 1 1
0 1 1
0 1 1
0 0 0
2 2 2rrent
N 
2
0
2
1
2
0
1
1
1
0
1
2
1
1
2
0ital.
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Volume 53, Number 4 Töpel et al 1017In three of 13 operating sites that received the flap
procedure for a graft at risk, an early prosthetic graft
infection could be detected during the postoperative
course (23%). In four of 34 patients operated for infected
grafts, the infection reappeared within three months
postoperatively (11%). In these four cases the infected
prosthetic graft had been replaced by an autologous vein
graft. The new or recurrent infection led to a loss of the
initial vascular reconstruction in five of these seven pa-
tients. There were no significant differences between the
SFA patent and SFA occluded group (Table II). Micro-
biology of new and recurrent infections is shown in
Table III. Two patients operated for severe graft infec-
tions died during the immediate postoperative period
from septic multi-organ failure (3% 30-day mortality).
Within the median follow-up time of 6.4 months, no
further deaths occurred.
Calcitrant lymphorrhea was the indication for the flap
procedure in nine patients (four SFA patent, five SFA
occluded). In two patients of the SFA patent group lym-
phorrhea persisted for further 5 days after the flap proce-
dure. Then, the drains could be removed. Follow-up did
not show any persistent fluid collections around the vascu-
lar structures or the flap (Table II).
DISCUSSION
The use of the proximal sartorius muscle transposition
flap as biologic protection procedure in the groin has been
widely described and is part of the standard surgical tech-
niques to treat infectious complications in the groin.1-3,6,7
In our study, the indication for the flap procedure was graft
infection (61%), graft at risk (23%), and calcitrant lymphor-
rhea (16%). In the majority of patients, a simultaneous
vascular procedure was necessary (autologous in 61%,
bovine/prosthetic in 18%). These data are reflected in the
patient populations of several recent publications.3,8,9
Microbial spectrum of surgical site infections is similar
to other reports in the literature6 (Table III).
In the group of patients operated for prosthetic graft
infections, early mortality rate of 6% (2/34 patients) and
Table V. Outcome and follow-up
SFA
patent
SFA
occluded All P
Follow-up
(months)
mean 5.8 6.6 6.4 1.000
Flap loss 0 2 (6.0%) 2 (3.5%) .513
Infection new/
recurrent 1/2 (13%) 2/2 (12%) 3/4 (12.5%) 1.000
Loss of
reconstruction 2 (9%) 3 (9%) 5 (9%) 1.000
Persistent
lymphorrhea 0 0 0 1.000
Limb salvage 23 (100%) 29 (88%) 52 (93%) .891
SFA, Superficial femoral artery.rate of recurrent infections with 12% (4/34 patients) are timilar to the results reported in the literature.5 Especially
atients with multi-resistant bacteria and patients under
mmunosuppressive therapy are prone to recurrent infec-
ions.10,11 Our microbiologic data show that in recurrent
nfection cases, increased bacterial resistance (E. coli ESBL
nd E. faecium) as well as fungal infections may have played
relevant role. Therefore, the need for accurate periopera-
ive microbiologic testing, including wound swaps and
raft specimen, has to be accentuated. In our opinion, in
atients with suspected or proven surgical site infections
alculated antibiotic therapy should be started not before
btaining graft specimen and wound swaps intraopera-
ively, whenever the patient’s medical condition allows to.
evertheless, an excellent limb-salvage rate of 93% was
chieved.
The new infections that occurred in two patients with
rosthetic grafts at risk (unilateral in one and bilateral in
nother patient) despite the biologic protection procedure
eem to argue for an increased risk of graft infections in
ertain patient groups (both patients were cachectic and
ad a history of alcohol abuse), although many risk factors
hought to increase wound infections following vascular
econstruction did not predict this complication in several
tudies.12,13 It has to be considered that the prophylactic
artorius flap procedure might present a possibly insuffi-
ient, but only calming concept to prevent impending
rosthetic graft infections. In some patients, it may prove to
e only a temporizing measure with an infection appearing
t a later date.
The proximal sartorius muscle flap as successful single-
ntervention therapy in groin lymphatic complications was
ecently appreciated.7 Soots and colleagues reported a
roup of 12 patients that were successfully treated for
ersistent lymphatic wound drainage after vascular surgery
n the groin.14 In our institution, we use this option, if
mmobilization, compressive dressings, and local radiother-
py (5  1 Gy) did not dry up the lymphorrhea. In nine
atients treated by wound revision and sartorius flap pro-
edure, the lymphatic drainage ceased. There were no early
r late wound infections.
Regarding the studies that describe the vascular anat-
my of the sartorius muscle, arterial blood supply generates
rom multiple segmental branches of the SFA.15-19 Mathes
nd Nahai gave a detailed description of the flap procedure
n a standard textbook of plastic and reconstructive sur-
ery.4 Given these data, vascular surgeons might hesitate to
tilize the sartorius muscle as transposition flap in patients
ith an occluded SFA. In contrast, Ramasastry and co-
orkers reported a blood supply of the proximal sartorius
uscle via branches of the medial and lateral femoral cir-
umflex arteries.5 They proposed that a patent PFA suffi-
iently supplies the muscle in the presence of an occluded
FA. These results are supported by our study. We did not
nd a difference between the SFA patent und the SFA
ccluded group concerning the flap viability. Obviously,
he failing flaps were due to technical mistakes and persis-
ent local infection with multi-resistant bacteria. We are
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group and the retrospective design. We believe that a
proximal sartorius muscle transposition flap is feasible in
vascular surgery patients even with an occluded SFA. It is a
simple and safe procedure to improve local wound condi-
tions and to promote integration of vascular grafts in in-
Table VI. Loss of vascular reconstruction: Case details an
Patient Initial reconstruction
Procedure simultaneous
with flap
S.W. 75-yo-
male
Aorto-bifemoral
prosthetic bypass
Problem: distal
insertion aneurysm
left groin
Aneurysm resection and
protheto-profundal
interpositon with a
Dacron graft;
Flap indication: graft
at risk (kachectic, bad
soft tissue coverage,
wound healing
disturbance after
identical procedure at
contralateral groin)
C
H.O. 56-yo-
male
Aorto-femoral and
protheto-popliteal
prosthetic bypass
Problem: Ischemic
rest pain
Initial reconstruction;
Flap indication: graft
at risk (kachectic, bad
soft tissue coverage)
E
P.E. 74-yo-
male
Femoro-popliteal
prosthetic bypass
Problem: Ischemic
rest pain
Graft explantation and
femoro-popliteal vein
bypass;
Flap indication:
prosthetic graft
infection
Szilagyi 3
C
S.W. 75-yo-
male
Resection of a distal
insertion aneurysm
and protheto-
profundal
interpositon with a
dacron graft right
groin after aorto-
bifemoral prosthetic
bypass Problem:
Wound dehiscence
Debridement;
Flap indication: graft
at risk
C
L.B. 87-yo-
female
Thrombembolectomy
CFA and PFA with
bovine patch
Problem: Early
bovine graft
infection
Resection of bovine
patch, venous patch;
Flap indication:
bovine graft infection
Szilagyi 3
Sfected fields. aONCLUSIONS
Our data support the concept of biologic protection
rocedures in vascular surgery. With the sartorius muscle
ap as part of a complex surgical management of infectious
omplications of vascular procedures in the groin, we can
nagement
crobiology
Loss of reconstruction
management
Flap status
at revision Outcome
lase-negative
hylococci
New prosthetic graft
infection Szilagyi 3
with periprothetic
abscess (three
months after flap
procedure)
Resection of
protheto-
profundal
interposition graft
and protheto-
profundal deep-
vein bypass
Viable Follow-up: 26
months
Primary
patency: 26
months
Amputation:
no
Recurrent
infection: no
cocci
etobacter
annii
New prosthetic graft
infection Szilagyi 3
with fistula
Explantation of all
prosthetic material,
aorto-femoral
deep-vein bypass
and femoro-
popliteal vein bypass
(GSV), primary
wound closure
Viable Follow-up: 6
months
Primary
patency: 6
months
Amputation:
no
Recurrent
infection: no
lase-negative
hylococci
eus vulgaris
siella
oca (ESBL)
rococci;
li (ESBL)
dida albicans
Persistent graft
infection Szilagyi 3
with arrosion
bleeding, flap
necrosis;
Partial bypass
resection and
venous
interposition graft,
rectus femoris flap
Necrotic Follow-up: 3
months
Primary
patency: 3
months
Amputation:
yes, above
knee
Recurrent
infection: no
lase-negative
hylococci
New prosthetic graft
infection Szilagyi 3
with periprothetic
abscess;
Resection of
protheto-
profundal
interposition graft
and protheto-
profundal deep-
vein bypass
Viable Follow-up: 30
months
Primary
patency: 30
months
Amputation:
no
Recurrent
infection: no
lococcus
us
Recurrent graft
infection Szilagyi 3
with arrosion
bleeding;
Resection of
venous patch,
femoro-femoral
venous
interposition graft
Viable Follow-up: 7
months
Primary
patency: 7
months
Amputation:
no
Recurrent
infection: nod ma
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Volume 53, Number 4 Töpel et al 1019reinfection. The concept of prophylactic biologic protec-
tion procedures in grafts at risk has to be the object of
further clinical investigations. The sartorius muscle trans-
position flap may be a valuable option in the treatment of
calcitrant lymphorrhea in the groin after vascular proce-
dures. Our findings suggest that the patency of the SFA has
no influence on the viability of the sartorius muscle flap,
wound healing, and limb salvage rate.
The authors thankMs Katrin Wurdinger for her help in
preparing the manuscript.
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